Acute respiratory distress syndrome (ARDS) continues to be a tough nut to crack in critical care, taking lives despite years of research and better ventilator strategies. It is defined by acute ...

Healios KK ( ($JP:4593) ) has issued an update. Healios KK has completed regulatory consultations in Japan for its investigational ARDS treatment ...

The following is a summary of "Heme-induced lung injury in human precision-cut lung slices: a new model for acute lung injury ...

For patients with moderate to severe acute respiratory distress syndrome (ARDS), prolonged sedation with the inhaled volatile agent sevoflurane resulted in worse outcomes than intravenous propofol ...

THE respiratory-distress syndrome, or hyalinemembrane disease, is the commonest cause of death among newborn, especially premature, infants, and yet its pathogenesis remains a mystery and its ...

In mechanically ventilated patients with ARDS, the treatment effect of neuromuscular blockade on mortality likely varies with respiratory elastance.

Inhaled sedation with sevoflurane in patients with moderate to severe acute respiratory distress syndrome (ARDS) resulted in fewer ventilator-free days at 28 days and lower 90-day survival than ...

Why it matters: The medical device startup is charting a new way to alleviate acute respiratory distress syndrome (ARDS) — a potentially deadly condition where a person's lungs fill with fluid ...

InflaRx (NASDAQ:IFRX) has received EU regulatory approval for its treatment Gohibic for the treatment of COVID-19 patients experiencing acute respiratory distress. The European Commission granted ...

VQ Biomedical, spun out of Duke University, has developed a novel, minimally invasive catheter designed to deliver oxygen directly to the bloodstream. The catheter bypasses the lungs, giving ARDS ...

Considering taking supplements to treat acute respiratory distress syndrome ards? Below is a list of common natural remedies used to treat or reduce the symptoms of acute respiratory distress ...